HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 22, 21384-21393, June 3, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/22/21384    most recent M408851200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morel, C. Articles by Martinez, J. Search for Related Content PubMed PubMed Citation Articles by Morel, C. Articles by Martinez, J. Social Bookmarking                      What's this?

Cross-interactions of Two p38 Mitogen-activated Protein (MAP) Kinase Inhibitors and Two Cholecystokinin (CCK) Receptor Antagonists with the CCK1 Receptor and P38 MAP Kinase^*

Caroline Morel, Géraldine Ibarz, Catherine Oiry, Eric Carnazzi, Gilbert Bergé, Didier Gagne, Jean-Claude Galleyrand, and Jean Martinez

From the Laboratoire des Aminoacides, Peptides, et Protéines, CNRS Unite Mixte de Recherche-5810, UMI et UMII, UFR Pharmacie, 15, Avenue Charles Flahault, 34093 Montpellier Cedex 5, France

Although SB202190 and SB203580 are described as specific p38 MAP kinase inhibitors, several reports have indicated that other enzymes are also sensitive to SB203580. Using a pharmacological approach, we report for the first time that compounds SB202190 and SB203580 were able to directly and selectively interact with a G-protein-coupled receptor, namely the cholecystokinin receptor subtype CCK1, but not with the CCK2 receptor. We demonstrated that these compounds were non-competitive antagonists of the CCK1 receptor at concentrations typically used to inhibit protein kinases. By chimeric construction of the CCK2 receptor, we determined the involvement of two CCK1 receptor intracellular loops in the binding of SB202190 and SB203580. We also showed that two CCK antagonists, L364,718 and L365,260, were able to regulate p38 mitogen-activated protein (MAP) kinase activity. Using a reporter gene strategy and immunoblotting experiments, we demonstrated that both CCK antagonists inhibited selectively the enzymatic activity of p38 MAP kinase. Kinase assays suggested that this inhibition resulted from a direct interaction with both CCK antagonists. Molecular modeling simulations suggested that this interaction occurs in the ATP binding pocket of p38 MAP kinase. These results suggest that SB202190 and SB203580 bind to the CCK1 receptor and, as such, these compounds should be used with caution in models that express this receptor. We also found that L364,718 and L365,260, two CCK receptor antagonists, directly interacted with p38 MAP kinase and inhibited its activity. These findings suggest that the CCK1 receptor shares structural analogies with the p38 MAP kinase ATP binding site. They open the way to potential design of either a new family of MAP kinase inhibitors from CCK1 receptor ligand structures or new CCK1 receptor ligands based on p38 MAP kinase inhibitor structures.

Received for publication, August 3, 2004 , and in revised form, March 15, 2005.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 33-4-67-54-86-60; Fax: 33-4-67-54-86-54; E-mail: jean-claude.galleyrand{at}univ-montp1.fr.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. D. Tran and J. T. Neary Purinergic signaling induces thrombospondin-1 expression in astrocytes PNAS, June 13, 2006; 103(24): 9321 - 9326. [Abstract] [Full Text] [PDF]

				M. O'Hayre, L. Taylor, M. Andratsch, E. Feifel, G. Gstraunthaler, and N. P. Curthoys Effects of Constitutively Active and Dominant Negative MAPK Kinase (MKK) 3 and MKK6 on the pH-responsive Increase in Phosphoenolpyruvate Carboxykinase mRNA J. Biol. Chem., February 3, 2006; 281(5): 2982 - 2988. [Abstract] [Full Text] [PDF]